<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2022, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 07 Apr 2022 11:42:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html</guid>
   <pubDate>Thu, 07 Apr 2022 11:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2171</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCRT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html</guid>
   <pubDate>Thu, 07 Apr 2022 11:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2171</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCRT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html</guid>
   <pubDate>Thu, 07 Apr 2022 11:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2171</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCRT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer</title>
   <link>http://www.streetinsider.com/PRNewswire/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html</guid>
   <pubDate>Thu, 07 Apr 2022 11:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2171</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCRT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer</title>
   <link>http://www.streetinsider.com/PRNewswire/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html</guid>
   <pubDate>Thu, 07 Apr 2022 11:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2171</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCRT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer</title>
   <link>http://www.streetinsider.com/PRNewswire/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/CARsgen+Appoints+Dr.+Raffaele+Baffa+as+Chief+Medical+Officer/19889220.html</guid>
   <pubDate>Thu, 07 Apr 2022 11:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2171</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCRT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Form  8-K        Alaunos Therapeutics,     For: Jan 25</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Alaunos+Therapeutics%2C+++++For%3A+Jan+25/19505797.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Alaunos+Therapeutics%2C+++++For%3A+Jan+25/19505797.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Alaunos+Therapeutics%2C+++++For%3A+Jan+25/19505797.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:28:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Ziopharm Oncology (ZIOP) Rebrands to Alaunos Therapeutics, Issues Operational Update</title>
   <link>http://www.streetinsider.com/Guidance/Ziopharm+Oncology+%28ZIOP%29+Rebrands+to+Alaunos+Therapeutics%2C+Issues+Operational+Update/19505718.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Ziopharm+Oncology+%28ZIOP%29+Rebrands+to+Alaunos+Therapeutics%2C+Issues+Operational+Update/19505718.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Guidance/Ziopharm+Oncology+%28ZIOP%29+Rebrands+to+Alaunos+Therapeutics%2C+Issues+Operational+Update/19505718.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:07:27 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Ziopharm Oncology (ZIOP) Rebrands to Alaunos Therapeutics, Issues Operational Update</title>
   <link>http://www.streetinsider.com/Corporate+News/Ziopharm+Oncology+%28ZIOP%29+Rebrands+to+Alaunos+Therapeutics%2C+Issues+Operational+Update/19505718.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ziopharm+Oncology+%28ZIOP%29+Rebrands+to+Alaunos+Therapeutics%2C+Issues+Operational+Update/19505718.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Ziopharm+Oncology+%28ZIOP%29+Rebrands+to+Alaunos+Therapeutics%2C+Issues+Operational+Update/19505718.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:07:27 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Ziopharm Oncology (ZIOP) Rebrands to Alaunos Therapeutics, Issues Operational Update</title>
   <link>http://www.streetinsider.com/Management+Changes/Ziopharm+Oncology+%28ZIOP%29+Rebrands+to+Alaunos+Therapeutics%2C+Issues+Operational+Update/19505718.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Ziopharm+Oncology+%28ZIOP%29+Rebrands+to+Alaunos+Therapeutics%2C+Issues+Operational+Update/19505718.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Ziopharm+Oncology+%28ZIOP%29+Rebrands+to+Alaunos+Therapeutics%2C+Issues+Operational+Update/19505718.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:07:27 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Ziopharm Oncology Highlights Operational Progress &amp;amp; Rebrands to Alaunos Therapeutics</title>
   <link>http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06311033</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Ziopharm Oncology Highlights Operational Progress &amp;amp; Rebrands to Alaunos Therapeutics</title>
   <link>http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06311033</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Ziopharm Oncology Highlights Operational Progress &amp;amp; Rebrands to Alaunos Therapeutics</title>
   <link>http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06311033</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Ziopharm Oncology Highlights Operational Progress &amp;amp; Rebrands to Alaunos Therapeutics</title>
   <link>http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06311033</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Ziopharm Oncology Highlights Operational Progress &amp;amp; Rebrands to Alaunos Therapeutics</title>
   <link>http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06311033</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Ziopharm Oncology Highlights Operational Progress &amp;amp; Rebrands to Alaunos Therapeutics</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06311033</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Ziopharm Oncology Highlights Operational Progress &amp;amp; Rebrands to Alaunos Therapeutics</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06311033</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Ziopharm Oncology Highlights Operational Progress &amp;amp; Rebrands to Alaunos Therapeutics</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06311033</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Ziopharm Oncology Highlights Operational Progress &amp;amp; Rebrands to Alaunos Therapeutics</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06311033</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Ziopharm Oncology Highlights Operational Progress &amp;amp; Rebrands to Alaunos Therapeutics</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Ziopharm+Oncology+Highlights+Operational+Progress+%26amp%3B+Rebrands+to+Alaunos+Therapeutics/19505539.html</guid>
   <pubDate>Wed, 26 Jan 2022 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06311033</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.33615634</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Form  8-K        ZIOPHARM ONCOLOGY INC     For: Dec 28</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Dec+28/19417434.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Dec+28/19417434.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Dec+28/19417434.html</guid>
   <pubDate>Tue, 04 Jan 2022 16:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Form  4          ZIOPHARM ONCOLOGY INC     For: Dec 22  Filed by: De Groot Eleanor</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Dec+22++Filed+by%3A+De+Groot+Eleanor/19392615.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Dec+22++Filed+by%3A+De+Groot+Eleanor/19392615.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Dec+22++Filed+by%3A+De+Groot+Eleanor/19392615.html</guid>
   <pubDate>Mon, 27 Dec 2021 12:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Form  4          ZIOPHARM ONCOLOGY INC     For: Dec 10  Filed by: Lackey Melinda</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Dec+10++Filed+by%3A+Lackey+Melinda/19340372.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Dec+10++Filed+by%3A+Lackey+Melinda/19340372.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Dec+10++Filed+by%3A+Lackey+Melinda/19340372.html</guid>
   <pubDate>Mon, 13 Dec 2021 06:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Form  3          ZIOPHARM ONCOLOGY INC     For: Nov 29  Filed by: Lackey Melinda</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Nov+29++Filed+by%3A+Lackey+Melinda/19332547.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Nov+29++Filed+by%3A+Lackey+Melinda/19332547.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Nov+29++Filed+by%3A+Lackey+Melinda/19332547.html</guid>
   <pubDate>Thu, 09 Dec 2021 14:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
  <item>
   <title>Form  3          ZIOPHARM ONCOLOGY INC     For: Nov 09  Filed by: Wong Michael</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Nov+09++Filed+by%3A+Wong+Michael/19284538.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Nov+09++Filed+by%3A+Wong+Michael/19284538.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ZIOPHARM+ONCOLOGY+INC+++++For%3A+Nov+09++Filed+by%3A+Wong+Michael/19284538.html</guid>
   <pubDate>Mon, 29 Nov 2021 18:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ZIOP</category>
   	  </item>
 </channel>
</rss>
